Physician profile

Anne J Parker

Nurse Practitioner · Asheville, NC

NPI 1366432619

$6,544.41

in general payments reported to CMS, 2019-2025

42 companies · $983 in 2025

The $983 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

See the full distribution for Nurse Practitioner

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,064.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,509.32 2021-2025
Lilly USA, LLC $556.23 2021-2025 Mounjaro, Zepbound, Jardiance
Pfizer INC. $418.37 2021-2025
Astrazeneca Pharmaceuticals LP $417.14 2021-2025 Farxiga, Airsupra, Breztri
Takeda Pharmaceuticals U.S.A., INC. $269.91 2021-2023 Trintellix
Novartis Pharmaceuticals Corporation $262.31 2021-2023
Novo Nordisk INC $243.75 2021-2024 Ozempic, Rybelsus
Janssen Pharmaceuticals, INC $210.24 2021-2023 Xarelto
Bayer Healthcare Pharmaceuticals INC. $208.42 2021-2024
Amgen INC. $187.29 2021-2024 Evenity, Prolia
Sanofi-Aventis U.S. LLC $179.81 2021-2023
Eisai INC. $175.90 2021-2025
Merck Sharp & Dohme LLC $173.38 2021-2023 Verquvo, Belsomra
Lundbeck LLC $160.78 2022-2025 Rexulti
Exact Sciences Corporation $156.39 2024-2025 The Cologuard Plus Collection Kit, Cologuard Collection Kit
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Otsuka America Pharmaceutical, INC. $153.45 2021-2025 Rexulti
Astellas Pharma US INC $135.72 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $111.12 2024-2025 Xifaxan
Endo Pharmaceuticals INC. $90.04 2021-2023 Aveed
Abbott Laboratories $89.26 2022-2024 Octrode, Freestyle Libre 3
Boehringer Ingelheim Pharmaceuticals, INC. $86.08 2021-2023 Jardiance, Synjardy, Tradjenta
Phathom Pharmaceuticals, INC. $83.32 2024 Voquezna
Esperion Therapeutics, INC. $74.98 2021-2022
Actelion Pharmaceuticals US, INC. $73.63 2024-2025 Uptravi, Opsumit
Glaxosmithkline, LLC. $69.78 2023-2024 Arexvy, Trelegy Ellipta, Shingrix
Corium, LLC $55.86 2022-2025 Azstarys
Amarin Pharma, INC. $50.56 2022
Harmony Biosciences LLC $44.73 2024
Tactile Systems Technology INC $35.29 2022
Inari Medical, INC. $26.67 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Verona Pharma, INC. $26.06 2025 Ohtuvayre
Daiichi Sankyo INC. $22.86 2021
Sumitomo Pharma America, INC. $22.47 2023 Aptiom
Alkermes, INC. $22.25 2024 Vivitrol
Idorsia Pharmaceuticals US INC $22.22 2022
Alexion Pharmaceuticals, INC. $22.11 2023 Strensiq
Biohaven Pharmaceuticals, INC. $17.93 2021
Amneal Pharmaceuticals LLC $16.50 2024 Unithroid
Seqirus USA INC $16.33 2024 Fluad, Flucelvax
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $15.86 2025 Caplyta
Boston Scientific Corporation $15.57 2021
Otsuka Pharmaceutical Development & Commercialization, INC. $14.52 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anne J Parker

$6,544.41

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $983 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

https://glasscript.com/doctor/10746346/anne-j-parker

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.